Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Partnership will conduct clinical trial of noninvasive cancer detection device
March 10th, 2005
SpectRx, Inc. (OTCBB: SPRX) and Emory University, Atlanta, Georgia, have created a partnership as part of a grant to Emory from the Georgia Research Alliance (GRA) to support U.S. Food and Drug Administration (FDA) pivotal clinical trials for a new non-invasive cervical cancer detection device. The $64,700 matching grant will be used for the clinical trial of the SpectRx-developed technology at Grady Memorial Hospital in Atlanta under the guidance of Lisa Flowers of Emory University. "We are very pleased to be working with Grady Hospital and Emory University of on this project," said Mark Faupel, president of Guided Therapeutics, Inc., the SpectRx...
Source: Women's Health Weekly (2005-03-10)
|
